We would like to respond to the recent publication by Matsumoto et al. "Milk ladder versus early oral immunotherapy in infants with cow's milk protein (CMP) allergy" which we read with interest 1 In this single center retrospective observational study the authors compared the efficacy and safety of milk ladder (ML) with early-oral immunotherapy (E-OIT) in children under the age of 2 years.